Covid19
Conditions
Keywords
Covid19, Pain, musculoskeletal
Brief summary
Worldwide, the COVID-19 pandemic continues to grow. Although COVID-19 mainly affects the lungs and internal organs, musculoskeletal injury from this disease was reported with the presentation of marked elevation in creatine kinase and lactate dehydrogenase levels. Patients with post-acute COVID-19 are considered patients with a post-intensive syndrome (PICS) that results in loss of functional independence. In the physical and rehabilitation medical field, various modalities with therapeutic exercise can be used to manage pain by a physical therapist and psychiatrist. Pain management is particularly important during the COVID-19 pandemic because of the reduced accessibility to hospitals and medical resources.
Detailed description
The COVID-19 survivors with pain symptoms will participated. In this phase, a face-to-face interview will be conducted to collecting all outcomes about pain.
Interventions
OTHERInterview
This interview will be conducted to collecting all outcomes about musculoskeletal pain in COVID-19 survivors
Sponsors
Fondazione Don Carlo Gnocchi Onlus
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Recovered from COVID-19 infection. * COVID-19 survivors after hospitalization. * Musculoskeletal pain.
Exclusion criteria
* Participants will be excluded also if they score greater than 6 points on the Beck Depression Inventory (BDI) or more than 30 points in the State Trait Anxiety Inventory (STAI), dementia and not Italian speaking due to the high level of language skills required for questionnaires and quantitative sensory testing. * Psychiatric or neurological disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-reported Version of the Leeds Assessment of Neuropathic Symptoms and Signs | Baseline | the characterization of the pain. Total of 24. \> 11 neuropathic pain. |
| PainDETEC | Baseline | the characterization of the pain |
| EuroQol-5D | Baseline | To measure quality of life, grade ranging from 0 (the worst possible health status) to 100 (the best possible health status) |
| The Hospital Anxiety and Depression Scale | Baseline | To measure psychological status. 0-7 = Normal; 8-10 = Borderline abnormal (borderline case), 11-21 = Abnormal (case) |
Countries
Italy
Contacts
Primary ContactJorge H Villafañe, Ph.D
Outcome results
None listed